ReviewEuropean journal of nuclear medicine and molecular imaging2021

2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework.

A Leuzy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.